HEC 93077
Alternative Names: HEC-93077Latest Information Update: 28 Dec 2024
Price :
$50 *
At a glance
- Originator Sunshine Lake Pharma
- Class Antigouts
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Gout
Most Recent Events
- 28 Dec 2024 No recent reports of development identified for phase-I development in Gout in China (PO)
- 25 Nov 2021 Sunshine Lake Pharma plans a phase I trial for Gout in China (NCT05127772)
- 25 Nov 2021 Preclinial trials in Gout in China (PO) (NCT05127772)